Elevated IgG responses in infants are associated with reduced prevalence of Mycobacterium tuberculosis infection by Logan, E, Luabeya, A, Mulenga, H, Mrdjen, D, Ontong, C, Cunningham, A, Tameris, M, McShane, H, Scriba, T, Horsnell, W, Hatherill, M

Impact of isoniazid preventive therapy on the evaluation of long-term effectiveness of infant MVA85A vaccination by Bunyasi, E, Luabeya, A, Tameris, M, Geldenhuys, H, Mulenga, H, Landry, B, Scriba, T, Schmidt, B, Hanekom, W, Mahomed, H, McShane, H, Hatherill, M

Inflammation and immune activation are associated with risk of Mycobacterium tuberculosis infection in BCG-vaccinated infants by Satti, I, Wittenberg, RE, Li, S, Harris, SA, Tanner, R, Cizmeci, D, Jacobs, A, Williams, N, Mulenga, H, Fletcher, HA, Scriba, TJ, Tameris, M, Hatherill, M, McShane, H

Safety and immunogenicity of newborn MVA85A vaccination and selective, delayed Bacille Calmette-Guerin (BCG) for infants of HIV infected mothers: A phase 2 randomized controlled tr... by Nemes, E, Hesseling, A, Tameris, M, Mauff, K, Downing, K, Mulenga, H, Rose, P, van der Zalm, M, Mbaba, S, Van As, D, Hanekom, W, Walzl, G, Scriba, T, McShane, H, Hatherill, M

Dose-finding study of the novel tuberculosis vaccine, MVA85A, in healthy BCG-vaccinated infants. by Scriba, T, Tameris, M, Mansoor, N, Smit, E, van der Merwe, L, Mauff, K, Hughes, E, Moyo, S, Brittain, N, Lawrie, A, Mulenga, H, de Kock, M, Gelderbloem, S, Veldsman, A, Hatherill, M, Geldenhuys, H, Hill, A, Hussey, G, Mahomed, H, Hanekom, W, Mcshane, H

A phase IIa trial of the new tuberculosis vaccine, MVA85A, in HIV- and/or Mycobacterium tuberculosis-infected adults. by Scriba, T, Tameris, M, Smit, E, van der Merwe, L, Hughes, E, Kadira, B, Mauff, K, Moyo, S, Brittain, N, Lawrie, A, Mulenga, H, de Kock, M, Makhethe, L, Janse van Rensburg, E, Gelderbloem, S, Veldsman, A, Hatherill, M, Geldenhuys, H, Hill, A, Hawkridge, A, Hussey, G, Hanekom, W, McShane, H, Mahomed, H